2-amino-4-[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl-methylamino]butanoic acid

This compound is a pharmaceutical intermediate used in the synthesis of impurities related to adenosine monophosphate. It features a complex structure containing purine and amino acid moieties, with multiple polar functional groups contributing to its hydrophilic nature.